Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does trastuzumab emtansine's patent expiry affect drug prices?When will generic fiasap insulin be available?Can wine consumption affect lipitor's cholesterol lowering ability?When genetic tenofovir alafenamide be available in us?Brenzavvy discontinuation?
See the DrugPatentWatch profile for kesimpta
Kesimpta (ofatumumab) is manufactured by Novartis facilities. The specific manufacturing site(s) depend on the product presentation and supply chain for the batch used in Australia, so the exact location is typically confirmed on the product packaging and/or the Australian medicines dossier for that batch.
For the most accurate answer for a particular pack, check the carton or the leaflet for: - the “manufactured by” company and site address, and - the batch/lot information that corresponds to the shipped supply to Australia.
If you need the precise factory location for a procurement, import, or regulatory submission, ask the Australian distributor/pharmacy supplier for the batch-level manufacturing details tied to your lot number.
Other Questions About Kesimpta :